AU2001268737A1 - Methods to screen for antibiotic agents and their use in treatment of opportunistic infections - Google Patents

Methods to screen for antibiotic agents and their use in treatment of opportunistic infections

Info

Publication number
AU2001268737A1
AU2001268737A1 AU2001268737A AU6873701A AU2001268737A1 AU 2001268737 A1 AU2001268737 A1 AU 2001268737A1 AU 2001268737 A AU2001268737 A AU 2001268737A AU 6873701 A AU6873701 A AU 6873701A AU 2001268737 A1 AU2001268737 A1 AU 2001268737A1
Authority
AU
Australia
Prior art keywords
screen
treatment
methods
opportunistic infections
antibiotic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268737A
Inventor
Anton Borovjagin
Susan Gerbi
Thilo Sascha Lange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brown University Research Foundation Inc
Original Assignee
Brown University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brown University Research Foundation Inc filed Critical Brown University Research Foundation Inc
Publication of AU2001268737A1 publication Critical patent/AU2001268737A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001268737A 2000-06-30 2001-06-28 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections Abandoned AU2001268737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21557200P 2000-06-30 2000-06-30
US60215572 2000-06-30
PCT/US2001/020520 WO2002001953A1 (en) 2000-06-30 2001-06-28 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections

Publications (1)

Publication Number Publication Date
AU2001268737A1 true AU2001268737A1 (en) 2002-01-14

Family

ID=22803502

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268737A Abandoned AU2001268737A1 (en) 2000-06-30 2001-06-28 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections

Country Status (3)

Country Link
US (1) US6913889B2 (en)
AU (1) AU2001268737A1 (en)
WO (1) WO2002001953A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790184B2 (en) * 2006-08-01 2010-09-07 Washington University In St. Louis Cytochrome c synthesis inhibitors
WO2012012443A2 (en) 2010-07-19 2012-01-26 Bennett C Frank Modulation of dystrophia myotonica-protein kinase (dmpk) expression
US10000557B2 (en) * 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
TW201536329A (en) 2013-08-09 2015-10-01 Isis Pharmaceuticals Inc Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
US11833221B2 (en) 2021-09-01 2023-12-05 Ionis Pharmaceuticals, Inc. Oligomeric compounds for reducing DMPK expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981692A (en) * 1983-03-24 1991-01-01 The Liposome Company, Inc. Therapeutic treatment by intramammary infusion
WO1998012346A1 (en) * 1996-09-23 1998-03-26 The Children's Hospital Of Philadelphia COMPOSITIONS AND METHODS FOR TREATMENT OF INFECTION CAUSED BY HAEMOPHILUS INFLUENZAE AND $i(STREPTOCOCCUS PNEUMONIAE)

Also Published As

Publication number Publication date
US20030203378A1 (en) 2003-10-30
WO2002001953A1 (en) 2002-01-10
US6913889B2 (en) 2005-07-05

Similar Documents

Publication Publication Date Title
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2001288432A1 (en) Materials and methods to potentiate cancer treatment
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2001272935A1 (en) Cobalamin compounds useful as antibiotic agents and as imaging agents
AU1525101A (en) Absorbent bodies for applying to skin and mucusa surfaces
AU1166502A (en) Human ect2 and methods of use
HUP0301815A3 (en) Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
EP1173193A4 (en) Desleucyl glycopeptide antibiotics and methods of making same
AU5250901A (en) Methods and devices for reducing trembling
GB2353612B (en) Processing by use of synchronised tuple spaces and assertions
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2003279526A1 (en) Identifying and treating vaginal infections
AU5114000A (en) P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
AU2002239485A1 (en) Methods for improved diagnosis and treatment of mycobacterial infections
AU2001268737A1 (en) Methods to screen for antibiotic agents and their use in treatment of opportunistic infections
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
AU3501700A (en) Human endokine alpha and methods of use
AU2002228660A1 (en) Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2003267948A8 (en) Aminoglycoside antibiotics and methods of using same